{"schema":"hottub-news/story/v1","story":"st_ozvtiegpm2y6pbj3zliq","title":"비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부","title_en":"What to do if you experience vision problems after taking obesity treatment?... Food and Drug Administration advises caution","outlets":5,"brief":null,"page":"https://hottub.news/stories/what-to-do-if-you-experience-vision-problems-after-taking-obesity-ozvtiegpm2","count":6,"items":[{"id":"n_xdptdtrgqf5navo7bhxq","seq":9843085,"kind":"article","title":"\"비만치료제 투여 후 시력 저하 땐 즉시 진료 권고\"","url":"https://news.sbs.co.kr/news/endPage.do?cooper=RSSREADER&news_id=N1008841706&plink=RSSLINK","summary":"식품의약품안전처가 GLP-1 계열 비만치료제 투여 후 시력 저하가 의심되면 투여를 중단하고 즉시 진료를 받으라고 권고했습니다.또 국내 시판 중인…","published":"2026-11-11T12:05:55Z","seen":"2026-11-11T12:26:00Z","lang":"ko","country":"KR","source":{"id":"kite-news-sbs-co-kr-dbe1f7","name":"news.sbs.co.kr","domain":"news.sbs.co.kr"},"via":"kite-news-sbs-co-kr-dbe1f7","topics":["사회","조성현 기자","8뉴스","sbs 뉴스","일반기사","glp-1 계열","미국 식품의약국","비만치료제"],"authors":["author"],"image":"https://img.sbs.co.kr/newimg/news/20261111/202240138.jpg","story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.9399999976158142,"sentiment":"negative","tone":-0.4000000059604645,"political":0.07999999821186066},{"id":"n_gtbesqy73fqkv6c7tisq","seq":9683510,"kind":"article","title":"식약처, 비만치료제 사용 중 ‘시력 저하’ 땐 즉시 의료진 상담 당부","title_en":"The Food and Drug Administration urges immediate consultation with medical staff if 'vision loss' occurs while using obesity treatment drugs","url":"https://www.hani.co.kr/arti/society/health/1286752.html","published":"2026-11-11T02:08:00Z","seen":"2026-11-11T02:08:00Z","lang":"ko","country":"KR","source":{"id":"kite-hani-co-kr-dbc6b3","name":"hani.co.kr","domain":"hani.co.kr","outlet":{"wikidata":"Q486314","name":"The Hankyoreh","type":"newspaper","country":"KR","designations":["newspaper"]}},"via":"kite-hani-co-kr-dbc6b3","mentions":2,"story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.9399999976158142,"sentiment":"negative","tone":-0.4300000071525574,"political":0.07000000029802322},{"id":"n_g7pf3u55phq75oacvhoa","seq":9690127,"kind":"article","title":"'비만치료제 맞고 시력 악화되면 투약 중단'… 식약처도 환자·의료진에 경고-사회ㅣ한국일보","url":"https://www.hankookilbo.com/news/article/A2026111109540005873","published":"2026-11-11T02:00:00Z","seen":"2026-11-11T02:55:00Z","lang":"ko","country":"KR","source":{"id":"hankookilbo.com","name":"hankookilbo.com","domain":"hankookilbo.com","outlet":{"wikidata":"Q489308","name":"Hankook Ilbo","type":"newspaper","country":"KR","designations":["newspaper"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["&#xC138","&#xC885","=&#xBC15","&#xACBD","&#xB2F4"],"story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.949999988079071,"sentiment":"negative","tone":-0.8899999856948853,"political":0.14000000059604645},{"id":"n_fgk266j3mzpt4up3c6sa","seq":9666864,"kind":"article","title":"비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부","url":"https://news.sbs.co.kr/news/endPage.do?cooper=RSSREADER&news_id=N1008840463&plink=RSSLINK","summary":"▲ GLP-1 계열 비만치료제식품의약품안전처는 GLP-1 계열 의약품 사용 시 비동맥 전방 허혈성 시신경병증이 의심되면 투약을 중단하…","published":"2026-11-11T00:44:14Z","seen":"2026-11-11T00:59:00Z","lang":"ko","country":"KR","source":{"id":"kite-news-sbs-co-kr-dbe1f7","name":"news.sbs.co.kr","domain":"news.sbs.co.kr"},"via":"kite-news-sbs-co-kr-dbe1f7","topics":["사회","조성현 기자","sbs 뉴스","일반기사","naion","경고","미국","의료진"],"authors":["author"],"image":"https://img.sbs.co.kr/newimg/news/20261110/202239761.jpg","mentions":2,"story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.9100000262260437,"sentiment":"neutral","tone":-0.41999998688697815,"political":0.03999999910593033},{"id":"n_ozvtiegpm2y6pbj3zliq","seq":9653451,"kind":"article","title":"비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부","title_en":"What to do if you experience vision problems after taking obesity medication?... FDA issues warning","url":"https://www.segye.com/newsView/20261111503314","summary":"식품의약품안전처는 글루카곤 유사 펩타이드-1(GLP-1) 계열 의약품 사용시 비동맥 전방 허혈성 시신경병증(NAION)이 의심되면 투약을 중단하도록 하는 내용의 '의약품 안전성 서한'을 배포했다고 11일 밝혔다. 이는 비만 치료 등에 사용하는 GLP-1 계열 의약품이 NAION 위험을 증가시킬 수 있다는 해외 안전성 정보에 따른 조처다. 앞서 미","published":"2026-11-10T23:40:13Z","seen":"2026-11-10T23:56:01Z","lang":"ko","country":"KR","source":{"id":"kite-segye-com-7df8f9","name":"segye.com","domain":"segye.com","outlet":{"wikidata":"Q624291","name":"Segye Ilbo","type":"newspaper","country":"KR","designations":["daily newspaper"]}},"via":"kite-segye-com-7df8f9","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.9100000262260437,"sentiment":"neutral","tone":-0.41999998688697815,"political":0.03999999910593033},{"id":"n_e64x7skz2toohangzkta","seq":9653642,"kind":"article","title":"비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부","title_en":"What to do if you experience vision problems after taking obesity treatment?... Food and Drug Administration advises caution","url":"https://www.yna.co.kr/view/AKR20261111027000017","summary":"(서울=연합뉴스) 신선미 기자 = 식품의약품안전처는 글루카곤 유사 펩타이드-1(GLP-1) 계열 의약품 사용시 비동맥 전방 허혈성 시신경병증(N...","published":"2026-11-10T23:35:50Z","seen":"2026-11-10T23:57:03Z","lang":"ko","country":"KR","source":{"id":"kite-yna-co-kr-c9ae1b","name":"yna.co.kr","domain":"yna.co.kr","outlet":{"wikidata":"Q333206","name":"Yonhap News Agency","type":"news_agency","country":"KR","designations":["news agency"]}},"via":"kite-yna-co-kr-c9ae1b","authors":["신선미"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://img.yna.co.kr/photo/cms/2026/10/13/05/PCM20261013000105990_P2.jpg","mentions":4,"story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.9100000262260437,"sentiment":"neutral","tone":-0.41999998688697815,"political":0.03999999910593033}]}